Ngaba udala kakhulu unyango?
Xa kufikelele kwiminyaka, i-multiple sclerosis (MS) ayicacisi. Nangona uninzi lwabantu luphakathi kweminyaka engama-20 ukuya ku-50 xa zifunyaniswa, ngokubhekiselele kwiSizwe soMbutho we-MS lesi sifo singabetha abantu abadala. Ukuba usandula ukufumanisa ukuba unayo i-MS kwaye uneminyaka engama-50s okanye i-60 okanye ngaphaya kwakho, unokungenakho ukhetho olufanayo olufana nomntu omncinci, kodwa oku akuthethi ukuba awukho nazikhethelo.
Wena kunye ne-neurologist yakho uya kuhamba malunga nezicwangciso zokulawula i-MS eziya kusebenza ngokugqithiseleyo kuwe, kodwa akusizi buhlungu ukuba ufumane ulwazi oluthe ngqo xa uhlala phantsi ukuze uxoxe ngazo. Nazi ezinye izinto ozaziyo malunga ne- MS unyango kubantu abadala.
Indlela Uhlobo lwe-MS olumisela ngayo unyango
Uninzi lwabantu abahlakulela i-MS kamva ebomini banesimo esiqhubekayo sesifo, apho kukho ukuhla kwexesha elide kunye nokunyanisekileyo emsebenzini ngenxa yomonakalo ongunaphakade kwiisondlo. Ngokuqhelekileyo iqala ngeengxaki zokuhamba-unyawo-ukudonsa okanye ukuqina komnye okanye kwimilenze yomibini. Ngaphezulu kweenyanga kunye neminyaka, iqondo lokukhubazeka landa.
Oku kuhambelani nokubuyiswa kwakhona kwe-MS (RRMS) apho abantu abaneentlobo zokukhubazeka ezihamba kunye nexesha lezinto eziqhelekileyo-ezenzeka ngenxa yesiganeko sokuhlaselwa kwamagciwane kwi-myelin, isithintelo sokukhusela esifubeni. Xa uhlaselo luphelile, iimpawu ze-MS zinyamalale.
Ngenxa yokungafani phakathi kweentlobo ezimbini eziphambili ze-MS, kulula ukubona indlela amayeza athile angenakusebenza ngayo kwelinye. Amachiza ekunakekeleni i-RRMS abizwa ngokuba yi-DMTs (i-DMTs) yokuguqula izifo ezisebenza ngokujolisa kumasosha omzimba. Kukho amayeza anjalo anikezelwe yi-US Food and Drug Administration (FDA) ekuphatheni i-RRMS.
Ezi zimbini kuphela ezi zivunyiweyo zonyango lwe-MS, ngokubhekiselele kuMbutho weSizwe we-MS, kwaye nakwazo azivunyelwanga kuzo zonke iintlobo zesifo. Kubalulekile ukuba uqaphele ukuba kukho iintlobo ezintathu ze-MS eziqhubekayo: i-MS yokuqala (PPMS), i-MS eqhubekayo (SPMS), kunye ne-MS-PR (progressed-relapsing MS).
Iyeza lokuqala kumachiza angasetyenziswa ekuphatheni iifomu eziqhubekayo ze-MS ngu-Ocrevus (ocrelizumab). Esi sigqirha sinikezwa nge-intravenously, 600 mg kanye emva kweenyanga ezintandathu, ngaphandle kwecala lokuqala elihlukaniswe kwi-300-milligram (mg). Isiza sesibini, iNovantrone (mitoxantrone), ivunyiwe ukunyanga i-SPMS kunye ne-PRMS (kodwa akukho PPMS). Inikwe kwi-12 mg yezilingo nganye kwiinyanga ezintathu.
Njengawo nawaphi na amagqirha anamandla, zombini la mayeza anemiphumo emibi, kubandakanywa nezinye ezinokubangela ingxaki kubantu abadala. I-Ocrevus inganyusa izifo zokuphefumula. I-Novantrone, eyayiqala ukunyangwa ngumhlaza, inobungozi kunoma ubani oye waba ne-chemotherapy okanye unengxaki yeentliziyo.
Unyango lweMithi
Nangona amayeza enkqubo ye-MS inokuthi ithintele umntu omdala angalinganiswanga kwaye akakwazi ukukhuseleka, kukho ezininzi unyango olukhoyo ukuze luncede ngeempawu ze- MS .
Ezi ziquka unyango lomzimba ukunceda ukwakha amandla omzimba nokufundisa iindlela zokuhlawula ukulahlekelwa komsebenzi.
Uphulo lwe-Occupational (OT) lunokukunceda ukuba utshintshe ikhaya lakho ukuze ulungele ukusebenza kumida yakho ukuze uzinakekele. Oku kungabandakanya izinto ezifana nokufaka ibhentshi yokubhebha kwindawo yokuhlamba kunye nokulungisa kwakhona iikhabhinethi zekhitshi ukuze izinto ozifunayo zilula ukufikelela. Kananjalo ungafunda iindlela ezahlukeneyo zokuhambisa umzimba wakho nge-OT.
Umthombo
> I-National Multiple Sclerosis Society. ICliniki Bulletin. " Ukuguga nge-Multiple Sclerosis. " 2011.